Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2.

about

Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2.

Item

http://www.wikidata.org/entity/Q49926115

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Regulation of intestinal lipid ...... 1 and glucagon like peptide 2.

@en

Regulation of intestinal lipid ...... 1 and glucagon like peptide 2.

@nl

type

Item

label

Regulation of intestinal lipid ...... 1 and glucagon like peptide 2.

@en

Regulation of intestinal lipid ...... 1 and glucagon like peptide 2.

@nl

prefLabel

Regulation of intestinal lipid ...... 1 and glucagon like peptide 2.

@en

Regulation of intestinal lipid ...... 1 and glucagon like peptide 2.

@nl

P1476

Regulation of intestinal lipid ...... 1 and glucagon like peptide 2.

@en

P2093

Erin E Mulvihill

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Nitric oxide and peroxynitrite in health and disease

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

FATTY ACID ESTERIFICATION AND CHYLOMICRON FORMATION DURING FAT ABSORPTION. 1. TRIGLYCERIDES AND CHOLESTEROL ESTERS

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Biology of incretins: GLP-1 and GIP

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.

P304

95-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1097/MOL.0000000000000495

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29432213

http://www.w3.org/2001/XMLSchema#string

P921

P932

5882252

http://www.w3.org/2001/XMLSchema#string